Gerardo Turcatti (born 1959 in Montevideo, Uruguay) is a Swiss-Uruguayan chemist who specialises in chemical biology and drug discovery.

He is a professor at the École Polytechnique Fédérale de Lausanne (EPFL) and director of the Biomolecular Screening Facility at the School of Life Sciences there.

Discovering the world of life sciences while working at the biotech company Biogen during his studies, he pursued a career as a chemical biologist.

While working at the Glaxo Biomedical Research Institute in Geneva, he studied under Professor Horst Vogel at EPFL for an industry PhD thesis in chemistry and biochemistry titled "Novel fluorescence-based approaches to probe ligand recognition and structure of the tachykinin NK2 receptor".

The Swiss-based company invented and developed novel high throughput DNA sequencing technologies currently owned by Illumina.